Anxiety levels before biologic initiation and changes with treatment in patients with psoriatic arthritis: HUR-BIO biologic registry results

[1]  V. Santilli,et al.  New Viscoelastic Hydrogel Hymovis MO.RE. Single Intra-articular Injection for the Treatment of Knee Osteoarthritis in Sportsmen: Safety and Efficacy Study Results , 2021, Frontiers in Pharmacology.

[2]  D. Gladman,et al.  Depression and Anxiety Reduce the Probability of Achieving a State of Sustained Minimal Disease Activity in Patients With Psoriatic Arthritis , 2021, Arthritis care & research.

[3]  M. Invernizzi,et al.  Oxygen–Ozone Therapy in the Rehabilitation Field:State of the Art on Mechanisms of Action, Safety andEffectiveness in Patients with Musculoskeletal Disorders , 2021, Biomolecules.

[4]  R. Saggini,et al.  Integration of focal vibration and intra-articular oxygen–ozone therapy in rehabilitation of painful knee osteoarthritis , 2021, The Journal of international medical research.

[5]  P. Sfikakis,et al.  Introduction and switching of biologic agents are associated with antidepressant and anxiolytic medication use: data on 42 815 real-world patients with inflammatory rheumatic disease , 2020, RMD open.

[6]  T. Paolucci,et al.  Evaluation of the efficacy of intra-articular injective treatment with reticular hyaluronic acid (Mo.Re. Technology) in amateur athletes with over-use gonarthrosis , 2020, Medicina dello Sport.

[7]  Jamie Y Park,et al.  Epidemiology of depression and anxiety in patients with psoriatic arthritis: A systematic review and meta-analysis. , 2020, Seminars in arthritis and rheumatism.

[8]  M. V. van Driel,et al.  Real-world questions and concerns about disease-modifying antirheumatic drugs (DMARDs): a retrospective analysis of questions to a medicine call center , 2020, BMC Rheumatology.

[9]  K. Pile,et al.  Systematic review of depression and anxiety in psoriatic arthritis , 2019, International journal of rheumatic diseases.

[10]  A. Akdoğan,et al.  Change in PsAID-12 scores in patients continuing or discontinuing anti-TNF treatments in psoriatic arthritis: results from the HUR-BIO biologic registry , 2019, Clinical Rheumatology.

[11]  H. B. Hammer,et al.  Do depression and anxiety reduce the likelihood of remission in rheumatoid arthritis and psoriatic arthritis? Data from the prospective multicentre NOR-DMARD study , 2017, Annals of the rheumatic diseases.

[12]  K. Hyrich,et al.  Biologics registers in RA: methodological aspects, current role and future applications , 2017, Nature Reviews Rheumatology.

[13]  F. Salaffi,et al.  The 12-item Psoriatic Arthritis Impact of Disease Questionnaire: Construct Validity, Reliability, and Interpretability in a Clinical Setting , 2017, The Journal of Rheumatology.

[14]  I. Olivieri,et al.  Quality of life and unmet needs in patients with inflammatory arthropathies: results from the multicentre, observational RAPSODIA study. , 2015, Rheumatology.

[15]  D. Gladman,et al.  Depression and Anxiety in Psoriatic Disease: Prevalence and Associated Factors , 2014, The Journal of Rheumatology.

[16]  M. D. de Wit,et al.  A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative , 2014, Annals of the rheumatic diseases.

[17]  A. Carvalho,et al.  Anxiety and depressive symptoms and illness perceptions in psoriatic arthritis and associations with physical health‐related quality of life , 2012, Arthritis care & research.

[18]  D. Gladman,et al.  Psoriatic arthritis: epidemiology, clinical features, course, and outcome , 2005, Annals of the rheumatic diseases.

[19]  A. Calin,et al.  A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. , 1994, The Journal of rheumatology.

[20]  A. Calin,et al.  A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. , 1994, The Journal of rheumatology.